Purchase Order 75F40124P00105

Award Date 3/25/24
Potential Completion Date 4/30/24
Potential Value $25K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $98,725.00 firm fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. (FCDI), a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The contract is for the purchase of cardiomyocytes, which are heart muscle cells, and does not have a set-aside designation. FCDI is a key supplier of specialized cell products, particularly to the Department of Health and Human...
This contract award to Fujifilm Cellular Dynamics, Inc. (FCDI) is for the provision of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to the Food and Drug Administration (FDA). The $42,995 firm-fixed-price purchase order has a period of performance through December 31, 2024. FCDI is a foreign-owned, for-profit manufacturer of specialized human cell cultures, particularly those derived from induced pluripotent stem cells (iPSCs). The company has an extensive history of...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of human induced pluripotent stem cell-derived cells. The $26,680 contract is to provide specialized cell cultures, including cardiomyocytes, neurons, astrocytes, and hepatocytes, to support the FDA's active research program. The award has no set-aside designation and is a sole-source award,...
This is a $99,500.00 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The contract is for the supply of iCell Cardiomyocytes, a specialized cell product used in biomedical research, drug development, and toxicology screening. The contract has...
This $16,375.00 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned manufacturer of specialized human cell cultures derived from induced pluripotent stem cells (iPSCs). The contract is for the delivery of iCell Cardiomyocytes, which are biologically relevant human cardiac cells used to support biomedical research and drug development...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The contract has a ceiling value of $119,350.00 and is not set aside for small businesses. The contract is for the supply of "MYCELL AND ICELL...
This is a firm-fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a subsidiary of Fuji Photo Film Company LIMITED. The $18,195 contract is for the supply of induced pluripotent stem cell-derived human cardiomyocytes (iCell Cardiomyocytes). This specialized cellular product supports critical research initiatives, including drug development,...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The $11,940 contract is for the supply of cardiomyocytes (heart muscle cells) and does not have a small business set-aside designation. Fujifilm Cellular Dynamics has been a consistent provider of specialized cell products to various federal agencies,...
This federal contract award, valued at $23,850.00, was issued by the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The contract is designated as a Total Small Business set-aside and is for the delivery of CARDIOMYOCYTES, which are specialized cardiac muscle cells. Fujifilm Cellular Dynamics has a strong track record of supplying diverse...
This is a $124,070 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC) derived human cell products. The contract is for the delivery of iPSC-derived human neurons and astrocytes, which are biologically relevant cell types used to support biomedical...

The U.S. Food and Drug Administration (FDA), through its National Center for Toxicological Research (NCTR), awarded a $24,895.00 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. for the supply of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs), also referred to as "iCell Macrophages" from lot #106775. This sole-source procurement was conducted under the authority of FAR 13.106-1(b)(1) to support an approved scientific study (S00913) focused on characterizing a co-culture model of hiPSC-CMs and hiPSC-derived macrophages for the assessment of immune-cardiotoxicity. The purpose is to obtain the same lot of hiPSC-derived macrophages previously used in the initial study to maintain consistency. This contract has no set-aside designation, and Fujifilm Cellular Dynamics, Inc., as the prime contractor, is a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells.

Generated 3/26/24, 6:52 PM